I will be one of first longs to declare a victory for the shorts. Now, can shorts please crash this to the level they NEED and politely cover with your profits. Good fight! You guys are really the smart money, no arguing that.
Maybe the SHORTS are being PLAYED by the institutional investors. The slow yet unobtrusive accumulation of shares by institutions with a slow, steady price rise and rising SI tells me something else going on. It is curious I agree with many others here about that. all IMO
Not the worst ever but looking bad to say the least. I am frustrated that approval did not produce more value for me/us. It is obvious that the fundamentals have changed significantly for ETRM since awarded approval for VBLOC. If you look back at the stock crash in 2013 after the miss in Super superiority end point, you could assume many investors bailed out b/c FDA approval was less likely. Price went below $0.8. Since the stock topped off at $2.60 knowing this endpoint data full well and now we have extended data, new CE mark, and the ultimate FDA approval, the current share price is unrealistic (even with minimal dilution). I would call this the BOTTOM and and entry point or averaging point. Some would call this a gift.
One thing that concerns me is the need for capital and commercialization skills/strategy. And here comes the worst part of my thoughts...ETRM is a PERFECT buyout target for several large device/pharma companies. You know this based on all the factors lining up perfectly for such a scenario. If you don't believe that, it's ok, but its my opinion. Yes investing in a stock for a BO is rather ridiculous I know. However ETRM, with recent FDA approval, is one of the most unique companies in the bio-device space. Wait for your buyout and hope they don't dilute us too much trying to commercialize on their own in the meantime. This is all imho.
More interesting is the 8.5% of float? I get math telling me 71 million shares now. So was there dilution right after approval?
I already asked/demanded, lol. It is considered too coercive under their pharma regs. But reps detailed a spirometer vendor and visited local pulmonary clinics. Pts can have nursing visits only for fev1 test, also pcp/endo were given cpt codes for clinic spirometery charges. The resources are available. Pts do not mind getting the fev1 done in house or outside.
In case your SNY rep wont provide you a resource for hand held spirometers:
look up Medical Device Depot, Inc.
MicroDirect Microlife Digital Peak Flow Meter $75.00
Connector to use disposable mouthpieces (7983) [Add $20.00]
Spirotube, Type A, Disposable Mouthpieces, 500/case (29-7000) [Add $57.59]
The Microlife revolutionary peak flow meter with FEV1 is the doctor’s choice for managing diseases that restrict lung performance. This advanced meter for spirometry includes a digital diary and measures air flow velocity and volume (FEV1) to indicate early warning signs for impending asthmatic incidents or conditions.
Now, let's get those patients what they ask for!!
Oh? 75 million shares eh? Good, Ade! We can use the cash at ETRM
You better hope its not a few million more shorts setting up control though...imo
Case against your point:
Research transneuronix 2005-2006. It will tell you that answer.
C'mon longs don't be gullible. The actual MONEY trading is nothing for a million shares or even several million shares. This device is so BIG that 10s of millions of shares are needed to make any impact. We have not even seen the bigger investors yet..IMO